Post
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma – NBC News
- Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma NBC News
- Cancer treatment could face landmark moment with promising vaccine The Washington Post
- Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial STAT
- Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melano Business Wire
- Moderna, Merck mRNA cancer vaccine prevents melanoma from returning thehill.com